Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week

Trevor Simard; Dhruv Sarma; William R. Miranda; C. Charles Jain; Jason H. Anderson; Jeremy D. Collins; Abdallah El Sabbagh; Aravdeep Jhand; Tobias Peikert; Guy S. Reeder; Thomas M. Munger; Douglas L. Packer; David R. Holmes

doi:10.1016/j.jacc.2023.04.016

Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week

Trevor Simard, Dhruv Sarma, William R. Miranda, C. Charles Jain, Jason H. Anderson, Jeremy D. Collins, Abdallah El Sabbagh, Aravdeep Jhand, Tobias Peikert, Guy S. Reeder, Thomas M. Munger, Douglas L. Packer, David R. Holmes

Research output: Contribution to journal › Review article › peer-review

Abstract

Pulmonary vein stenosis (PVS) can arise from several etiologies, including congenital, acquired, and iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. A high index of suspicion and dedicated noninvasive evaluation are key to diagnosis. Once diagnosed, both noninvasive and invasive evaluation may afford further insights into the relative contribution of PVS to symptoms. Treatment of underlying reversible pathologies coupled with transcatheter balloon angioplasty and stenting for persistent severe stenoses are established approaches. Ongoing refinements in diagnostic modalities, interventional approaches, postintervention monitoring, and medical therapies hold promise to further improve patient outcomes.

Original language	English (US)
Pages (from-to)	2361-2373
Number of pages	13
Journal	Journal of the American College of Cardiology
Volume	81
Issue number	24
DOIs	https://doi.org/10.1016/j.jacc.2023.04.016
State	Published - Jun 20 2023

Keywords

atrial fibrillation ablation
fibrosing mediastinitis
pulmonary vein intervention
pulmonary vein isolation
pulmonary vein stenosis

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2023.04.016

Cite this

Simard, T., Sarma, D., Miranda, W. R., Jain, C. C., Anderson, J. H., Collins, J. D., El Sabbagh, A., Jhand, A., Peikert, T., Reeder, G. S., Munger, T. M., Packer, D. L., & Holmes, D. R. (2023). Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week. Journal of the American College of Cardiology, 81(24), 2361-2373. https://doi.org/10.1016/j.jacc.2023.04.016

Simard, T, Sarma, D, Miranda, WR, Jain, CC, Anderson, JH, Collins, JD, El Sabbagh, A, Jhand, A, Peikert, T, Reeder, GS, Munger, TM, Packer, DL & Holmes, DR 2023, 'Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week', Journal of the American College of Cardiology, vol. 81, no. 24, pp. 2361-2373. https://doi.org/10.1016/j.jacc.2023.04.016

@article{8f71446ba5d9497dab3bf3a123330cb4,

title = "Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week",

abstract = "Pulmonary vein stenosis (PVS) can arise from several etiologies, including congenital, acquired, and iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. A high index of suspicion and dedicated noninvasive evaluation are key to diagnosis. Once diagnosed, both noninvasive and invasive evaluation may afford further insights into the relative contribution of PVS to symptoms. Treatment of underlying reversible pathologies coupled with transcatheter balloon angioplasty and stenting for persistent severe stenoses are established approaches. Ongoing refinements in diagnostic modalities, interventional approaches, postintervention monitoring, and medical therapies hold promise to further improve patient outcomes.",

keywords = "atrial fibrillation ablation, fibrosing mediastinitis, pulmonary vein intervention, pulmonary vein isolation, pulmonary vein stenosis",

author = "Trevor Simard and Dhruv Sarma and Miranda, {William R.} and Jain, {C. Charles} and Anderson, {Jason H.} and Collins, {Jeremy D.} and {El Sabbagh}, Abdallah and Aravdeep Jhand and Tobias Peikert and Reeder, {Guy S.} and Munger, {Thomas M.} and Packer, {Douglas L.} and Holmes, {David R.}",

note = "Publisher Copyright: {\textcopyright} 2023 American College of Cardiology Foundation",

year = "2023",

month = jun,

day = "20",

doi = "10.1016/j.jacc.2023.04.016",

language = "English (US)",

volume = "81",

pages = "2361--2373",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "24",

}

TY - JOUR

T1 - Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis

T2 - JACC Review Topic of the Week

AU - Simard, Trevor

AU - Sarma, Dhruv

AU - Miranda, William R.

AU - Jain, C. Charles

AU - Anderson, Jason H.

AU - Collins, Jeremy D.

AU - El Sabbagh, Abdallah

AU - Jhand, Aravdeep

AU - Peikert, Tobias

AU - Reeder, Guy S.

AU - Munger, Thomas M.

AU - Packer, Douglas L.

AU - Holmes, David R.

PY - 2023/6/20

Y1 - 2023/6/20

N2 - Pulmonary vein stenosis (PVS) can arise from several etiologies, including congenital, acquired, and iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. A high index of suspicion and dedicated noninvasive evaluation are key to diagnosis. Once diagnosed, both noninvasive and invasive evaluation may afford further insights into the relative contribution of PVS to symptoms. Treatment of underlying reversible pathologies coupled with transcatheter balloon angioplasty and stenting for persistent severe stenoses are established approaches. Ongoing refinements in diagnostic modalities, interventional approaches, postintervention monitoring, and medical therapies hold promise to further improve patient outcomes.

AB - Pulmonary vein stenosis (PVS) can arise from several etiologies, including congenital, acquired, and iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. A high index of suspicion and dedicated noninvasive evaluation are key to diagnosis. Once diagnosed, both noninvasive and invasive evaluation may afford further insights into the relative contribution of PVS to symptoms. Treatment of underlying reversible pathologies coupled with transcatheter balloon angioplasty and stenting for persistent severe stenoses are established approaches. Ongoing refinements in diagnostic modalities, interventional approaches, postintervention monitoring, and medical therapies hold promise to further improve patient outcomes.

KW - atrial fibrillation ablation

KW - fibrosing mediastinitis

KW - pulmonary vein intervention

KW - pulmonary vein isolation

KW - pulmonary vein stenosis

UR - http://www.scopus.com/inward/record.url?scp=85160795256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160795256&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2023.04.016

DO - 10.1016/j.jacc.2023.04.016

M3 - Review article

C2 - 37316116

AN - SCOPUS:85160795256

SN - 0735-1097

VL - 81

SP - 2361

EP - 2373

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 24

ER -

Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this